What is Vimta Labs Ltd (VIMTALABS) share price today?

Vimta Labs Ltd (VIMTALABS) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/VIMTALABS for the latest live price, technical analysis, and AI-powered insights.

How to analyse VIMTALABS stock?

VestAI provides comprehensive VIMTALABS stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

Vimta Labs Ltd

Q: What sector is Vimta Labs Ltd in?

Vimta Labs Ltd (VIMTALABS) is in the Healthcare sector, Healthcare Research Analytics & Technology industry on the NSE.

Q: What is Vimta Labs Ltd's Orion Score?

Vimta Labs Ltd has an Orion Score of 72/100 (Quality) — a fundamentals-based quality & risk score. Vimta Labs Ltd scores 72/100 (Quality) on the Orion Score — strong business quality (78), strong growth (80), strong balance-sheet safety (85) and rich valuation (27). A fundamentals-based quality & risk score, not a buy/sell recommendation.

VIMTALABS

NSE· Healthcare

₹557.80

-8.30 (-1.47%)

Updated 09:16 am IST

52W Low · ₹391.8052W High · ₹902.65

Mid Range

Market Cap

₹2437.76L Cr

Volume

76.3K

Prev Close

₹558.90

ISIN

INE579C01029

Orion Score

Fundamentals-based quality & risk · not a recommendation

72/100

Quality

Vimta Labs Ltd scores 72/100 (Quality) on the Orion Score — strong business quality (78), strong growth (80), strong balance-sheet safety (85) and rich valuation (27). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.3× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 3/9Altman Z Safe(9.79)Beneish M Clean(-2.60)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

52/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.01x — lean balance sheet

QUALITY

Average

ROCE 19.7% — decent returns

MOMENTUM

Neutral

RSI 58.1 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 31.25
ROCE: 19.68%
ROE (1Y): 18.55%
D/E Ratio: 0.01x
OPM: 24.36%
TTM EPS: ₹17.42
Dividend Yield: 37.00%
Qtrly Sales: ₹109.25 Cr
Qtrly Profit: ₹21.11 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹109.25	₹21.11	24.4%	₹4.62
Q3 2026	₹98.63	₹17.59	23.6%	₹3.94
Q2 2026	₹101.85	₹19.92	23.6%	₹4.44
Q1 2026	₹97.56	₹18.89	24.4%	₹4.21
Q4 2025	₹94.44	₹18.32	25.2%	₹4.04

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹407.29	₹77.51	₹148.89	24.0%
FY 2025	₹343.98	₹67.34	₹126.63	25.2%
FY 2024	₹288.6	₹41.01	₹98.22	22.3%
FY 2023	₹315.06	₹48.17	₹96.64	22.1%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
VIMTALABS ★	₹2,438 Cr	31.25	19.68%	18.55%	0.01x	24.36%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹466.53	₹394.47	₹362.32	₹307.2
Equity	₹378.85	₹314.12	₹281.79	₹233.98
Total Debt	₹8.52	₹19.19	₹14.99	₹19.34
Cash	₹15.84	₹13.44	₹30.5	₹10.8
Net Debt	—	₹5.75	—	₹8.54
Working Capital	₹123.45	₹103.53	₹106.38	₹76.61

Shareholding Pattern

Q1 FY2027

Promoter

65.84%

FII

2.35%

DII

1.93%

Public

29.88%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	65.84% ↑	2.35% ↓	1.93% ↑	29.88% ↓
Q3 FY2026	35.89% ↓	4.59% ↑	0.11% ↓	59.4% ↑
Q2 FY2026	35.99% ↓	4.33% ↑	0.87% ↓	58.8% ↑
Q1 FY2026	36.67% ↓	3.49% ↓	1.42% ↓	58.42% ↑
Q4 FY2025	36.7% ↓	3.66% ↓	1.43% ↑	58.2% ↓
Q3 FY2025	36.76% ↓	3.81% ↑	1.15% ↑	58.28% ↓
Q2 FY2025	36.89%	3.31% ↓	0% ↓	59.8% ↑
Q1 FY2025	36.89%	5.16%	1.49%	56.45%

Corporate Actions

Ex-Date	Action	Details
2026-06-18	DIVIDEND	Dividend - Rs 2 Per Share

Funds Holding This Stock

1 mutual fund schemes

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.05%

₹0 Cr

Analyse VIMTALABS with Orion AI

Ask: "Is Vimta Labs Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Vimta Labs Ltd (VIMTALABS) Stock

Vimta Labs Ltd is listed on the NSE under the Healthcare sector, Healthcare Research Analytics & Technology industry. ISIN: INE579C01029. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.